Catalyst Wire Dossier Catalyst Wire Dossier
CLINICAL_TRIALS research · 2025-03-18

Clinical Trial Update: Efficacy of Resveratrol Containing Mouthwash in Reducing Halitosis Related Porphyrymonas Gingivalis. [Phase 3]

View source ↗

Summary

Phase 3 clinical trial assessing the efficacy of a resveratrol-containing mouthwash to reduce halitosis associated with Porphyromonas gingivalis; recruitment is…

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

Drugs mentioned

  • Resveratrol-containing mouthwash (resveratrol)

Snippet

Sponsor: Al-Mustansiriyah University | Conditions: Halitosis, Mouth Disease | Phase 3 | Status: RECRUITING